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Pigpen is a 67-kDa Sepharose-binding molecule isolated from mammalian endothelial and retinal pigmented epithelial
cells. The protein is distributed nonhomogeneously in the nucleus, exhibiting diffuse staining throughout (excluding
nucleoli), together with a small number of intensely stained focal points, or granules, and punctate staining along the
nuclear envelope. Pigpen was absent or greatly attenuated in the nonepithelial cell types we examined, including ®broblasts,
myeloma, and astroglia. cDNA sequence analysis revealed a positively charged molecule with an RNP-CS RNA-binding
domain, 19 RGG repeats, and a consensus tyrosine phosphorylation site in the C-terminus. The amino terminal portion
of the molecule is characterized by 7 glutamine-rich hexapeptide repeats similar to those found in the transactivation
domain of known transcription activators. Pigpen has a high level of identity with the FUS gene product, TLS (Translocated
in Liposarcoma; Crozat et al., 1993; Rabbits et al., 1993), a new member of the EWS family of proteins. Expression of
pigpen is regulated during the transition between active and quiescent endothelial cell phenotypes. Both mRNA and overall
protein levels are maintained at a steady level in actively growing cells. The number of nuclear granules increases as
cultures approach con¯uency. When cells reach con¯uency, overall expression is sharply reduced and the number of nuclear
focal points declines gradually. We observed that reactivation of endothelial cells locally by wounding of con¯uent cultures
resulted in a spatially restricted reactivation of pigpen expression. This pattern of expression, taken together with structural
data, suggests that pigpen may function in the growth and differentiation of endothelial cells during angiogenesis.
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INTRODUCTION riod, migrating cells join with one another into clusters,
and these clusters develop into branching and anastomosing
Angiogenesis is a multistep process that can be thought cords. Luminae eventually develop within the cords and
of as occuring in three phases: activation, morphogenesis, a patent, functioning capillary bed forms. In the terminal
and ``terminal'' differentiation. In the adult organism, the differentiation phase, EC revert to their normal, quiescent
endothelial cell (EC)1 population is a relatively static one. existence. It should be noted that the term ``terminal differ-
Except under certain circumstances, EC are nonprolifera- entiation'' is used loosely here, because the constitutive
tive, nonmigratory, and tightly regulated to remain that way endothelial phenotype is relatively unstable; cells are
(Klagsbrun, 1987). Triggered by a change in the microenvi- readily reactivated upon the occurence of a wound, cyclic
ronment, a dramatic phenotype switch occurs and cells are reproductive processes, or a persistent angiogenic stimulus
induced to delaminate from the endothelial monolayer, pro- like those found in neovascular disorders (reviewed in Au-
liferate, and migrate in a directed fashion. This is the activa- gustin-Voss et al., 1994).
tion phase. In the morphogenetic phase, cell±cell and cell± These events in endothelial morphogenesis are, obvi-
matrix interactions play a prominent role. During this pe- ously, a complicated continuim. The schematic given above
is not intended as a detailed description of the angiogenic
program, but is simply meant to serve as a framework for1 Abbreviations used: EN, echinonectin; EC, endothelial cells;
present discussion. As mentioned above, a key feature ofEWS, Ewing's sarcoma; RACE, rapid ampli®cation of cDNA ends;
this process is that ECs transdifferentiate between activatedRPE, retinal pigmented epithelium; TLS, transformed in liposar-
coma; VEGF, vascular endothelial growth factor. and constitutive phenotypes. The ability to mimic this phe-
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cells were cultured under routine conditions in minimal essentialnomenon in culture enables us to study certain aspects of
medium plus 15% fetal bovine serum and 100 U/ml penicillinangiogenesis under relatively controlled conditions, in
/ 100 mg/ml streptomycin (MEM-15). Four to six ml of pelleted,vitro. Not surprisingly, in light of clinical implications, a
manually harvested cells was homogenized and sonicated in 50great effort has been directed at identifying events and mole-
mM Tris, pH 7.5, containing 1% Triton X-100, 7 mM EDTA, andcules that trigger angiogenesis. The activation phase is,
1% DMSO. The homogenate was centrifuged at 30,000g for 45 min,
therefore, the best understood, though many important and an equal volume of homogenization buffer was added to the
questions remain to be answered. Synthesis, export, and supernatant. The sample was then subjected to af®nity chromatog-
receptor binding of peptide growth factors such as bFGF and raphy on a 1.5 1 2 cm column of Sepharose 4B at 47C. The column
VEGF have been studied in detail with considerable success was washed with at least 25 vol of 50 mM Tris/1% Triton, pH 7.5,
then 50 vol of 50 mM Tris/1 M NaCl, and eluted with 8 M urea in 50and reviewed extensively (see, for example: Augustin-Voss
mM Tris. Nuclear extraction of pigpen was effected using methodset al., 1994; Castellot, 1991; Folkman and Klagsbrun, 1987).
described by Maxwell (1994).A good deal is also known about the morphogenetic phase,
though perhaps less than the activation phase. The deposi-
tion and effects of extracellular matrix proteins and the
expression of their speci®c receptor molecules by EC have Immunological
been the subjects of fairly thorough investigation (reviewed
The 13202 polyclonal antiserum to EN polypeptide was producedby Carey, 1991). Far less, unfortunately, is known about the
and characterized as described previously using established meth-concluding phase of angiogenesis, although it is quite as
ods (Alliegro et al., 1988, 1990). EN (puri®ed by af®nity chromatog-
indispensible to the formation and maintenance of a work- raphy on Sepharose 4B and subsequently excised from SDS±poly-
ing capillary network as the two preceding phases. After acrylamide gels) was periodate-treated to disrupt carbohydrate epi-
new capillaries are formed and functioning, what genes are topes (Woodward et al., 1985) and used to immunize a female New
turned on, or off, to hold ECs in ``quiescent check''? In this Zealand white rabbit. Western blot techniques were performed as
context, our knowledge of nuclear structure and reorganiza- described by Towbin et al. (1979), with only minor modi®cation.
The detection system used was a peroxidase-conjugated goat anti-tion is particularly lacking.
rabbit 27 antibody, with H2O2 and 1,4-dichloronaphthol substrates.We have recently identi®ed a nuclear protein in cultured
All reagents for Western blotting were purchased from Sigma (St.EC and retinal pigmented epithelial cells (RPE) that we refer
Louis, MO). Slot blots were performed on a Hoefer minifold apparatusto as pigp67en. ``Pigpen'' was ®rst noted for its high immuno-
(San Francisco, CA) according to the manufacturer's handling recom-logical identity with the sea urchin galactose-speci®c lectin,
mendations. Western and slot blots were quantitated using M2 Image
echinonectin (EN; Alliegro et al., 1988). Similar to the sea Analysis Software (Imaging Research, Inc., Ontario, Canada).
urchin lectin, pigpen could be isolated by binding to Sepha- For immunocytochemistry, cells grown on sterile coverslips were
rose2 and appears to be absent or is attenuated in nonepithelial ®xed in 2.5% paraformaldehyde for 5 min, followed by 3 min in
cells. Expression of this molecule is regulated qualitatively 0.05% Triton X-100 and 8 min in methanol at 0207C. Primary
and quantitatively during growth of ECs in culture. Nonprolif- antiserum was used at a dilution of 1/500 to 1/1000 in PBS plus
1% normal goat serum. FITC-conjugated goat anti-rabbit IgG waserating cells synthesize pigpen at barely detectable levels. Un-
used for detection. Labeled specimens were viewed with a Leicader conditions where cells are actively migrating and dividing
(Heidelberg, Germany) confocal laser scanning microscope. To(i.e., in subcon¯uent or wounded cultures), pigpen expression
quantitate pigpen focal points in cells, microscopic ®elds at 6001is up-regulated. When cells reach con¯uency and are once
magni®cation were chosen at random, all cells in the ®eld wereagain quiescent, pigpen expression is sharply reduced.
assessed, and a new ®eld was brought into view until at least 50
These characteristics indicate a potential role for pigpen cells were included in counts.
in the growth and differentiation of ECs. Our goal is to
determine the factors that regulate pigpen expression in
such a manner and determine if the molecule has a causal
General Molecularrole in the transition from the active to the quiescent EC
phenotype. This initial report describes the isolation of pig- A bovine EC cDNA library in Lambda ZAP was obtained from
pen, its structural attributes, and its reorganization during Stratagene (La Jolla, CA) and screened with anti-EN according to
EC growth in culture. standard methodologies. Nested, unidirectional deletions were pre-
pared from cesium chloride-puri®ed plasmid DNA using the Pro-
mega (Madison, WI) Erase-a-Base system. Sequenase Version 2.0
MATERIALS AND METHODS (U.S. Biochemicals, Cleveland, OH) was used in cDNA sequencing.
Sequences were assembled and analyzed using IBI (New Haven,
Protein Isolation CT) MacVector software. RACE extensions were performed using
reagents from Clontech, Inc. (Palo Alto, CA). Reagents for mRNAPigpen was isolated using methods described previously for the
isolation were purchased from Invitrogen (Portland, OR) and Qia-puri®cation of Lytechinus variegatus EN (Alliegro et al., 1990). All
gen (Chatsworth, CA). The 675-bp ¯uoresceinated cDNA probe
used for Northern analysis was generated by PCR using sequence-
2 Sepharose is a trade name for agarose, a galactose polymer, and is speci®c primers described under Results. Reagents for probe syn-
thesis and detection were purchased from New England Nuclearused routinely as an af®nity matrix for galactose-speci®c lectins (see,
for example, Vasta and Marchalonis, 1986). (Boston, MA) and Perkin±Elmer Cetus (Norwalk, CT). Standard
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cell types (human ®broblasts expressed the antigen at very
low levels). The apparent size of the protein was consis-
tently 3±4 kDa larger in RPE. We do not know at this point
if the differential is due to additional amino acid residues
in the RPE polypeptide or to a difference in net charge.
As will be noted below, pigpen contains an abundance of
positive amino acids, which could readily affect its mobility
in SDS gels.
From this initial screening, our expectation is that pigpen
will primarily be found in epithelial cell types. This is true
of EN, which is concentrated in the blastula epithelium of
sea urchin embryos (Alliegro et al., 1988, 1990). We next
attempted to isolate the 67-kDa protein in a manner similarFIG. 1. Immunoblot identi®cation and cell type-speci®c expres-
to EN and the chick brain protein. When EC were homoge-sion of pigpen. Thirty-®ve micrograms of total cellular protein was
separated on a 7.5% SDS±polyacrylamide gel, transferred to nitro- nized and subjected to af®nity chromatography on Sepha-
cellulose, and probed with a polyclonal antibody directed against rose 4B using the same protocol developed for EN, the 67-
the polypeptide moiety of L. variegatus EN. (A) Immunoblot using kDa immunoreactive polypeptide was retained on the col-
antiserum diluted at 1/1000. (B) Coomassie blue stain. Lanes 1, umn through detergent and high-salt washes and eluted
human corneal ®broblasts; lanes 2, pig RPE; lanes 3, human RPE; with 8 M urea. The polypeptide was recovered in much
lanes 4, fetal bovine aortic EC; lanes 5, monkey RPE; lanes 6, hu-
lower yield than was EN, being detectable only by silverman astrocytes; lanes 7, human choroidal capillary EC; lanes 8,
staining of SDS gels. This could be due to either low contentmouse myeloma. Mr standards are shown at right.
within cells or imperfect isolation methods. As will become
apparent from subsequent data, enrichment by cell fraction-
ation prior to af®nity chromatography should provide us
Northern blotting techniques were used in pigpen mRNA expres- with a more effective approach if quantities of protein are
sion studies (Sambrook et al., 1989). required in future studies.
Confocal immuno¯uorescent images of pigpen in EC (Fig.
2) showed diffuse staining throughout the nucleus (but ex-RESULTS cluded from nucleoli), punctate staining along the inner
aspect of the nuclear envelope, and several brightly stained
Initial Identi®cation of Pigpen focal points, or granules. These focal points were present
in the nuclei of approximately 85% of all cells examined.Using polyclonal anti-EN antibodies, we had previously
observed a 70-kDa Sepharose-binding protein in homoge- They varied in number and sometimes appeared to be ar-
ranged in a radial pattern. Occasionally, the larger of thesenates of 10-day chick embryo brain on Western blots (Allie-
gro and Alliegro, unpublished observations). Our prelimi- granules seemed to have a hollow core, appearing as a cylin-
der in cross section.nary ®ndings suggested that this molecule was expressed
in the epithelial lining of brain ventricles, but low-level We fractionated EC to determine on Western and slot blots
if pigpen was associated with a speci®c nuclear compartment.speci®c staining did not allow detection of antigen against
background staining in surrounding tissues. Since protein The results are shown in Fig. 3. Greater than 80% of recovered
pigpen was found in the fraction released by DNase treatment.levels were low and the cell population was small, we de-
cided to pursue the observation in a system more amenable Quantities found in the membrane/cytoplasmic, high-salt,
and nuclear matrix fractions were considerably less and variedto manipulation and biochemical analysis, choosing human
EC and RPE to begin with. When RPE or EC lysates were somewhat from assay to assay. The results show that pigpen
is associated with chromatin, but do not distinguish betweenprobed on Western blots with polyclonal anti-EN (No.
13202), a single band developed at approximately 67 kDa a direct and an indirect association.
(Fig. 1). Recognition of this polypeptide is remarkably in-
tense and speci®c: the band becomes visible within seconds
Sequence Analysisof substrate addition, and dilutions of primary antibody as
great as 1/10,000 can be used. Results with preimmune se- The 13202 antibody was used to screen a bovine EC cDNA
library, and a 1675-bp clone designated pp9 was identi®ed.rum from the same rabbit were negative. We typically use
the serum at a dilution of 1/1000. The same polypeptide The sequence was extended in the 3* and 5* directions by
RACE (rapid ampli®cation of cDNA ends). The cDNA andband can be detected on Western blots with a different poly-
clonal antibody to EN (described and used in Alliegro et al., deduced amino acid sequence are shown in Fig. 4. Pigpen is
a highly hydrophilic and positively charged protein, with an1988), though not with the same intensity.
In Western blots using a variety of cell types and probed estimated pI of 9.65. A ``greek key'' hairpin loop motif
(Graeme and Piatagorsky, 1988) and an RNP-CS RNA-bindingwith the 13202 antibody, a single band was detected in all
RPE and EC examined (Fig. 1), but not in the nonepithelial domain (Adam et al., 1986; Sachs et al., 1987) were identi®ed
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FIG. 2. Immuno¯uorescence confocal micrograph showing pigpen distribution in cultured endothelial cells. (A) Immune serum diluted
1/500. (B) Preimmune at the same dilution. Arrowheads highlight areas of punctate staining along the nuclear envelope. The cells shown
in C and D are atypical in that they exhibit lower levels of the diffuse nuclear staining seen in the majority of cells. They were chosen
to better illustrate nuclear envelope staining as well as the morphology of individual granules. (E) Includes a cell in metaphase. Condensed
chromatin (arrow) appears in negative relief against diffuse staining now dispersed in the cytoplasm. Scale bar, 10 mm.
in the middle one-third of the sequence. The latter is found from liposarcoma, TLS (Transformed in Liposarcoma; Cro-
zat et al., 1993; Rabbits et al., 1993). TLS is a 68-kDa RNA-in several known RNA-binding proteins, including the bicoid
gene product from Drosophila melanogaster (Rebagliati, 1989) binding nuclear protein, and a new member of the EWS
family of proteins. In human myxoid liposarcomas, theand the EWS (Ewing's sarcoma) family of proteins isolated
from human tumors (Delattre et al., 1992). The N-terminus characteristic t(12;16)(q13;p11) chromosomal translocation
results in FUS gene fusion to CHOP (CEBP HOmologousincludes seven copies of a degenerate glutamine-rich hexapep-
tide repeat sequence found in the transactivation domains of Protein) DNA. CHOP has been proposed to act as a cell
cycle checkpoint protein at the G1/S boundary (Barone etcertain transcription factors (Mitchell and Tijan, 1989; May
et al., 1994). The C-terminus contains a consensus tyrosine al., 1994)). The FUS/CHOP fusion is thought to negate this
function of CHOP. TLS activity as a fusion protein in car-phosphorylation site, but we have not yet determined if the
protein is a physiological kinase substrate. Nineteen RGG cinogenic transformation is the subject of rapidly progress-
ing investigation (Barone et al., 1994; Ichikawa et al., 1994;repeats, also associated with RNA-binding proteins (Kiledjian
and Dreyfuss, 1992), are present in the C-terminal two-thirds Prasad et al., 1994; Zinszner et al., 1994; Panagopoulus et
al., 1994; Sanchez-Garcia and Rabbits, 1995; Knight et al.,of the polypeptide. The sequence also contains several N-
glycosylation sites, but migration of the protein in SDS gels 1995). Owing to its recent discovery, little is known of its
function in normal cells.(as determined by Western blotting and subsequent probing
with the 13202 antibody) was unaffected by exhaustive N-
Pigpen Expression Is Regulated during Endothelialglycosidase treatment (data not shown).
Cell TransdifferentiationComparison of the predicted amino acid sequence with
protein sequence data banks revealed approximately 80% Given its identity with TLS and the latter's hypothesized
role in deregulating the cell cycle in carcinogenesis, weidentity with the recently discovered FUS gene product
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in compacted, quiescent ECs was the punctate staining ob-
served on the nuclear envelope of actively dividing cells.
Down-regulation of pigpen expression could occur at any
of several levels ranging from transcriptional control to se-
lective proteolytic degradation of the polypeptide. To exam-
ine this question further, a 675-bp cDNA probe generated
by PCR from the 5* end of pp9 was prepared for Northern
analysis. On blots of EC mRNA, the probe hybridized with a
single, 1.9-kb transcript. This result was in good agreement
with the estimated size of pigpen from both sequence analy-
sis and SDS±polyacrylamide gels. As anticipated from our
earlier observations, the 1.9-kb transcript was expressed at
much lower levels in human ®broblasts (Fig. 6). We next
found, in experiments patterned after the Western analysis
above, that pigpen mRNA expression followed a course
identical to pigpen protein levels. In the transition from
actively dividing to quiescent cells, mRNA levels plum-
metted by more than 95%.
Based on the premise that pigpen expression is regulated
during the transition from activated to constitutive EC phe-
FIG. 3. Pigpen distribution in fractionated endothelial cell prepa- notype, we reasoned that localized reactivation of EC by
rations. Cells were harvested nonenzymatically and separated into wounding the compacted monolayer should also reactivate
four fractions as described by Maxwell (1994). Thirty-®ve micro-
pigpen expression. In this experiment, cultures were growngrams of each fraction was loaded on SDS±polyacrylamide gels for
on sterile coverslips for several days beyond con¯uency,Western blots (shown here), or 10 mg each for slot blots. Results
wounded with a sterile pipet tip, and prepared at severalusing these two methods were very similar. After probing the nitro-
timepoints thereafter for immuno¯uorescence. As can becellulose sheets, results were quantitated by densitometry. The
absorbance level for each fraction is presented as a percentage of seen in Fig. 7, we found that quantitative and qualitative
total units recovered. Cyt/mem, cytoplasmic/membrane fraction; differences in pigpen expression occurred. These changes
DNase, proteins released from nuclear pellet by DNase treatment; were restricted to the wound. Nuclei of reactivated cells
High salt, proteins extracted from DNase-insensitive fraction with were again stained brightly with the 13202 antibody. Nu-
1 M NaCl; Matrix, proteins remaining in nuclear pellet after se- clear envelope staining reappeared. The number of nuclear
quential DNase and high-salt extractions. focal points in the wounded zone was also increased from
approximately 4 per nucleus (off-wound) to 12. The inci-
dence of nuclear focal points appeared to increase by an
additional factor as a result of treatment with VEGF, butsought to determine if pigpen could have a functional role
in EC growth and differentiation. Speci®cally, we asked if not with bFGF. Unique to these wound experiment cells
was the appearance of cytoplasmic granules. In growth fac-pigpen was regulated during the transition between active
and quiescent EC phenotypes. ECs were seeded into a six- tor-treated preparations, an occasional binucleate cell was
observed with a striking, perinuclear array of large granules.well plate at a density of 8 1 104 cells/well and harvested
at timepoints chosen to represent various phases of con¯u- Their distinct organization in the cytoplasm suggested an
association with cytoskeletal elements. Wounding in theency from sparse, actively dividing cultures to compacted,
contact-inhibited ones. On Western blots, expression of the presence of bFGF, but not VEGF, increased the number of
these cytoplasmic granules over and above that observed byprotein was observed to be highest in subcon¯uent cultures
(Fig. 5A). Promptly on the day when cells were scored visu- wounding alone.
A survey of animal tissues by immunoblot revealed aally as 100% con¯uent, pigpen levels dropped precipitously
and stayed low for at least 4 days thereafter (the duration restricted distribution and was consistent with the notion
that pigpen is expressed under growth conditions. In addi-of the experiment). Chronologically, cells cultured in the
presence of VEGF down-regulated pigpen levels earlier than tion to embryonic chick brain, pigpen was found in rat pup
spleen and liver. The protein was not detectable in anyeither bFGF- or untreated cells, but this may have occurred
because they reached con¯uency more rapidly. normal adult tissue we examined, including spleen and
liver, muscle, eye, kidney, gut, and brain. Tissue samplesImmuno¯uorescent images obtained from parallel cul-
tures corroborated this observation and provided additional were excised from rat, mouse, rabbit, cow, and cat. A series
of low Mr bands was detected in human skin carcinoma.detail. Diffuse nuclear staining declined to levels just above
background. Nuclear granules increased in number by more The development of new antibody probes useful for immu-
nohistochemistry will help us to obtain a more detailedthan twofold until con¯uency (Fig. 5B) and then declined
gradually to baseline levels on Day 9 (although remaining picture of precisely which cells in these tissues are express-
ing pigpen, and to what relative degree.somewhat elevated in bFGF-treated cells). Completely gone
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FIG. 4. Nucleotide and deduced amino acid sequence of pigpen. Nucleotide numbering is on the left, and amino acid position is given
on the right. Underscored nucleotide sequences in the 3* UTR include the stop codon, TAG, and the noncanonical polyadenylation signal,
ATTAAA. Underscored amino acid sequences include: the seven glutamine-rich consensus [(SG)Y(SG)Q(QS)S(SQP)] repeats in the putative
transactivation domain (residues 24 through 159); RNP-2 and RNP-1 motifs within the RNP-CS RNA-binding domain (residues 320±327
and 272±278, respectively); greek key loop motif (residues 337±348); consensus tyrosine phosphorylation site (residues 462±468). These
sequence data are available from GenBank under Accession No. U26024.
in an organism can vary between, and even within, individ-DISCUSSION
ual organs, the overriding common characteristic is their
quiescent nature. Several molecules that can activate ECsAngiogenesis has been described as a developmental pro-
and others that are regulated later during capillary morpho-cess that is down-regulated in the healthy adult (Augustin-
Voss et al., 1994). Although the constitutive EC phenotype genesis have been identi®ed. Virtually all of these are re-
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reactivation of pigpen expression in those cells at the wound
site. Cells distant from the wound, which maintain the
quiescent phenotype, do not reactivate pigpen expression.
Confocal immuno¯uorescence microscopy of pigpen in
ECs was used to reveal its distribution in the nucleus. In
actively proliferating cells, the protein is distributed
throughout the nucleoplasm (excluding nucleoli) and is con-
centrated along the nuclear envelope and in brightly stained
nuclear granules. Nuclear envelope staining is attenuated
as cells approach con¯uency, whereas granules appear to
increase in number. This may represent a redistribution
of pigpen between two compartments during a change in
physiological status or these two inversely related observa-
tions may have no direct link. Our data do not distinguish
between the two possibilities.
The structure and distribution of pigpen-containing nu-
clear granules is reminiscent of previously described speck-
led or granular domains within the nucleus (reviewed by
Spector, 1993; Gall, 1991). These granules may represent
sites of mRNA transcription and/or processing. However,
the behavior of pigpen-containing granules did not quite
parallel the patterns expected for these other, well-charac-
terized molecules (Spector, 1993). For example, the cyto-
plasmic array of pigpen-containing granules induced by
wounding seems to depart from observations on snurpo-
some reorganization. It is possible that pigpen-containing
granules are distinct from previously de®ned speckles or
coiled bodies, but at this point it is equally likely that pig-
pen is distributed between two or more known nuclear gran-
ules (complicating the pattern of reorganization) or that the
speci®c conditions we employed in our studies revealed
modi®ed patterns of reorganization. In the future, colocal-FIG. 5. Pigpen expression during endothelial cell growth in cul-
ture. (A) Quantitative Western blot analysis. Cells were plated on ization of pigpen with components of previously de®ned
Day 0. The sample taken on Day 1 (l) was considered as initial
expression (100%). Subsequent data are presented as a percentage
of the Day 1 level. (l) MEM-15; (s) MEM-15 /10 ng/ml bFGF; (j)
MEM-15 /10 ng/ml VEGF. In this experiment cells in MEM-15
reached con¯uency on Day 4. VEGF- and bFGF-treated cells
reached con¯uency by Day 3. (B) Quantitation of pigpen-containing
nuclear granules during endothelial cell growth in culture. Each
point represents the mean ({SEM) number of nuclear granules for
50 cells examined. In this experiment, cells reached con¯uency on
Day 3.
lated to cell surface events (reviewed in Augustin-Voss et
al., 1994; Castellot, 1991; Folkman and Klagsbrun, 1987).
Clearly, many important details of how these molecules
launch the angiogenic cascade, and how the endothelium
FIG. 6. Down-regulation of pigpen mRNA during endothelial cellis held in ``quiescent check,'' are yet to be de®ned.
growth. A cDNA probe complementary to nucleotides 50±725 wasWe have identi®ed a 67-kDa nuclear protein (pigpen) in
used in Northern analyses. (A) Hybridization to a 1.9-kb messagehuman microvascular and bovine aortic ECs that is ex-
in EC (lane 1) and human foreskin ®broblasts (lane 2). (B) Pigpen
pressed during their active phase and whose expression is mRNA levels in EC judged subjectively to be approximately 70%
greatly reduced during their quiescent phase. In cultured con¯uent (lane 3), 85% con¯uent (lane 4), 95% con¯uent (lane 5),
cells, both mRNA and protein levels fall dramatically when con¯uent (lane 6), and con¯uent /24 hr (lane 7). Two micrograms
cells achieve con¯uency. Wounding of the EC monolayer, of poly(A)/ RNA loaded per lane. Kilobase standards are shown at
right.inducing cell migration and proliferation, results in strong
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FIG. 7. Localized reactivation of pigpen expression in con¯uent cultures by wounding. (A and B) Areas on (within 1 mm) and off (5
mm from) the wound site, respectively. (C) A wounded area in a culture treated with 10 ng/ml bFGF. The ``wounds'' in A and C are up
and to the right of the cells in the micrographs (note the orientation of cells in these two panels). (D) Binucleate cell in the wound area
of a VEGF-treated culture (10 ng/ml), exhibiting a pronounced radial array of pigpen-containing granules in the cytoplasm. Cytoplasmic
granules were observed in many growth factor-treated cells, but this striking degree of organization was seen primarily in the occasional
binucleate cell. Scale bar, 10 mm.
nuclear compartments should help to characterize pigpen- munological cross-reactivity with sea urchin EN, some dis-
cussion of the possible relationship between these two mol-containing nuclear granules more fully.
Sequence analysis of pigpen suggests that it is a member ecules is warranted. Our study has revealed several features
that pigpen appears to share with EN. Both proteins can beof a growing family of RNP-CS RNA-binding proteins. The
deduced primary structure shows80% identity with TLS. isolated by an af®nity for Sepharose 4B. EN is known to be
a galactose-speci®c lectin (Veno et al., 1990, Alliegro et al.,The level of identity in the C-terminus, containing the con-
sensus RNA-binding elements, approaches 100%. It has re- 1990); the question of pigpen carbohydrate speci®city has
not yet been addressed. In addition, both proteins seem tocently been shown that TLS, like pigpen, localizes with a
speckled pattern in the 3T3 cell nucleus (Barone et al., be expressed preferentially in epithelial cells. EN is concen-
trated in the blastula epithelium, whereas pigpen has been1994). TLS was subsequently found to be associated with
RNA polymerase II products in immunoprecipitation exper- identi®ed in RPE and ECs. Last, the expression of both pro-
teins may be restricted to proliferating cell populations. ENiments. If the similarities between TLS and pigpen can be
extended in this context, then the isolation of pigpen in expression is down-regulated in primary mesenchyme cells,
which cease dividing shortly after ingression into the blasto-the DNase soluble fraction of EC nuclei may represent an
indirect association with chromatin via nascent mRNA coele; pigpen expression is minimal in nonproliferating cell
cultures. Pigpen and EN, however, are not the same protein.chains. Given the transactivation-like domain in the pigpen
amino terminus, a direct association with DNA must also EN is a glycosylated, dimeric protein composed of two 116-
kDa subunits, whereas pigpen is apparently nonglycosyl-remain a consideration.
Because pigpen was originally identi®ed by its strong im- ated, non-disul®de bonded, and has a Mr of approximately
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isolation and sequencing and identi®cation of a ribonucleopro-67 kDa. Moreover, EN is distributed in the cortical cyto-
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